ILEVRO
nepafenac
- Strength
- 3 mg/mL
- Form
- Suspension/ Drops
- Class
- Nonsteroidal Anti-inflammatory Drug
Harrow Eye, LLC
Not stocked by us — reference only
nepafenac
Listed by Harrow Eye, LLC
| Dosage form | Suspension/ Drops |
|---|---|
| Route | Ophthalmic |
| Drug class | Nonsteroidal Anti-inflammatory Drug |
| Approval route | NDA — original brand approval |
| NDC code | 82667-500 |
| FDA application | NDA021862 |
| RxNorm concept | 578044 |
| Package sizes listed | 1 |
| Marketed since | January 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
nepafenac
Harrow Eye, LLC
Not stocked by us — reference only
nepafenac
Novartis Pharmaceuticals Corporation
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.